ArticleMedComm2026

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma.

Mingming Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.